THOMAS FRANK E
Insider CIK 1242616 · ZFGN Director · SPRO Director · ORTX See Remarks · AMAG President & COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-20 | 55,150 | — | $0 | 55,150 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 5,000 | $5.00 | $25.0K | 7,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2025-05-13 | 2025-05-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2024-05-29 | 2024-05-31 | 19,000 | — | $0 | 19,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-14 | 2024-02-15 | 2,000 | $11.00 | $22.0K | 2,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 309,990 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 149,990 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 99,980 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 27,730 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 335,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 457,800 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 75,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 405,590 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 179,390 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 199,990 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer | 2024-01-24 | 2024-01-24 | 92,081 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2023-05-09 | 2023-05-11 | 8,300 | — | $0 | 8,300 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise deriv | 2023-03-10 | 2023-03-14 | 20,000 | — | $0 | 335,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise | 2023-03-10 | 2023-03-14 | 20,000 | $0.46 | $9.2K | 92,081 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2023-03-01 | 2023-03-03 | 179,400 | — | $0 | 179,400 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2023-03-01 | 2023-03-03 | 405,600 | — | $0 | 405,600 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise deriv | 2023-02-09 | 2023-02-13 | 20,000 | — | $0 | 355,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise | 2023-02-09 | 2023-02-13 | 20,000 | $0.46 | $9.2K | 72,081 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 100,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 184,229 | — | $0 | 184,229 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 184,229 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 426,185 | — | $0 | 426,185 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 426,185 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 200,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 150,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 310,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 310,000 | — | $0 | 310,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2022-10-04 | 2022-10-06 | 27,731 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 27,731 | — | $0 | 27,731 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-10-04 | 2022-10-06 | 457,811 | — | $0 | 457,811 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-06-01 | 2022-06-03 | 375,000 | — | $0 | 375,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2022-05-10 | 2022-05-12 | 8,300 | — | $0 | 8,300 | SEC↗ |
| ORTX Orchard Therapeutics plc | P Buy | 2022-04-01 | 2022-04-04 | 10,000 | $0.75 | $7.5K | 52,081 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2022-01-05 | 2022-01-07 | 2,214 | $9.03 | $20.0K | 2,214 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2021-05-12 | 2021-05-17 | 8,300 | — | $0 | 8,300 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2021-02-01 | 2021-02-03 | 310,000 | — | $0 | 310,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2021-02-01 | 2021-02-03 | 27,731 | — | $0 | 27,731 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise deriv | 2021-01-29 | 2021-02-01 | 10,000 | — | $0 | 426,185 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise | 2021-01-29 | 2021-02-01 | 10,000 | $2.44 | $24.4K | 42,081 | SEC↗ |
| ORTX Orchard Therapeutics plc | F Tax w/h | 2021-01-11 | 2021-01-12 | 3,706 | $6.72 | $24.9K | 32,081 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award | 2021-01-08 | 2021-01-12 | 10,667 | — | $0 | 35,787 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 1,314 | $13.31 | $17.5K | 1,314 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2020-09-29 | 2020-09-30 | 16,600 | — | $0 | 16,600 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 436,185 | SEC↗ |
| ORTX Orchard Therapeutics plc | M Exercise | 2020-06-11 | 2020-06-15 | 10,000 | $2.44 | $24.4K | 25,120 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2020-04-01 | 2020-04-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2020-01-02 | 2020-01-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 2,704 | $6.47 | $17.5K | 2,704 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2019-06-26 | 2019-06-27 | 27,000 | — | $0 | 27,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2018-06-06 | 2018-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2017-06-21 | 2017-06-23 | 14,500 | — | $0 | 14,500 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2017-02-23 | 2017-02-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2017-02-23 | 2017-02-27 | 12,000 | — | $0 | 138,195 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2017-02-23 | 2017-02-27 | 12,000 | — | $0 | 126,195 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-06-30 | 2016-07-01 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2016-03-01 | 2016-03-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2016-03-01 | 2016-03-01 | 17,000 | — | $0 | 114,195 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2016-02-29 | 2016-03-01 | 515 | $26.28 | $13.5K | 97,195 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2016-02-27 | 2016-03-01 | 458 | $27.01 | $12.4K | 97,710 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2016-02-26 | 2016-03-01 | 7,417 | $27.01 | $200.3K | 99,529 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2016-02-26 | 2016-03-01 | 1,361 | $27.01 | $36.8K | 98,168 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2015-08-20 | 2015-08-21 | 2,363 | $61.71 | $145.8K | 106,946 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | M Exercise deriv | 2015-08-05 | 2015-08-07 | 15,000 | — | $0 | 45,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | M Exercise | 2015-08-05 | 2015-08-07 | 15,000 | $14.91 | $223.7K | 124,309 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | S Sale | 2015-08-05 | 2015-08-07 | 15,000 | $66.85 | $1.00M | 109,309 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2015-07-13 | 2015-07-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | S Sale | 2015-06-04 | 2015-06-08 | 7,996 | $69.76 | $557.8K | 109,309 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | S Sale | 2015-06-04 | 2015-06-08 | 12,004 | $69.27 | $831.5K | 117,305 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2015-03-03 | 2015-03-05 | 4,279 | $49.70 | $212.7K | 129,309 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2015-02-26 | 2015-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2015-02-26 | 2015-02-27 | 12,500 | — | $0 | 133,588 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2014-12-17 | 2014-12-18 | 7,046 | $40.49 | $285.3K | 121,088 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2014-08-19 | 2014-08-21 | 30,000 | — | $0 | 128,134 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2014-08-19 | 2014-08-21 | 10,000 | — | $0 | 98,134 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2014-06-24 | 2014-06-26 | 13,327 | — | $0 | 13,327 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2014-02-27 | 2014-02-28 | 33,800 | — | $0 | 33,800 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2014-02-27 | 2014-02-28 | 5,600 | — | $0 | 88,134 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2013-12-16 | 2013-12-17 | 3,266 | $23.23 | $75.9K | 82,534 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2013-02-28 | 2013-03-04 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2013-02-28 | 2013-03-04 | 12,500 | — | $0 | 40,800 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2013-02-28 | 2013-03-04 | 6,300 | — | $0 | 28,300 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | M Exercise deriv | 2013-01-03 | 2013-01-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | M Exercise | 2013-01-03 | 2013-01-04 | 20,000 | — | $0 | 32,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | S Sale | 2013-01-03 | 2013-01-04 | 10,000 | $15.60 | $156.0K | 22,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | M Exercise deriv | 2012-11-30 | 2012-12-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | M Exercise | 2012-11-30 | 2012-12-04 | 10,000 | — | $0 | 17,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | S Sale | 2012-11-30 | 2012-12-04 | 5,000 | $15.08 | $75.4K | 12,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | C Conversion deriv | 2012-08-01 | 2012-08-03 | 5,000 | — | $0 | 15,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | C Conversion | 2012-08-01 | 2012-08-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-04-02 | 2012-04-02 | 500 | $15.86 | $7.9K | 2,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-03-01 | 2012-03-02 | 500 | $15.81 | $7.9K | 1,500 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-02-01 | 2012-02-02 | 500 | $16.56 | $8.3K | 1,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-01-03 | 2012-01-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-01-03 | 2012-01-04 | 500 | $19.10 | $9.6K | 500 | SEC↗ |